Newborn Screening Market Set to Take Off by 2027 To Gather Huge Revenues
Newborn Screening Market Set to Take Off by 2027 To Gather Huge Revenues
Published by Coherent Market Insights
Posted on September 27, 2021

Published by Coherent Market Insights
Posted on September 27, 2021

Newborn Screening Market report includes historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. Newborn Screening Market offers complete, proficient report delivering market research data that is relevant for new market entrants or set up players. Key strategies of the companies operating in the market and their impact analysis have been included in the report.
Request for Sample Copy of Report at – https://www.coherentmarketinsights.com/insight/request-sample/2192
New born screening is a public health program conducted by various hospitals where new born babies are screened and identified with rare but some serious medical conditions (genetic, hormonal, or metabolic conditions) which can affect normal growth of the new born but are treatable.
New born screening includes various tests such as hearing test, urine test, dry blood test, and others, that are undertaken during initial few hours or days of an infant’s life. These tests have the potential role in preventing several health problems and death. New born screening has evolved from a simple blood and urine screening test to a more comprehensive and complex screening system for detecting over 50 different conditions. New born screening tests measures different types of markers present in infant’s blood that can either increase or decrease, if an infant has certain diseases. Recently, conditions such as congenital hypothyroidism, phenylketonuria (PKU), cystic fibrosis (CF), and about 22 other metabolic conditions can be diagnosed through new born screening tests that affect fat metabolism or protein.
The global new born screening market is estimated to be valued at US$ 1,412.2 million in 2021 and is expected to exhibit a CAGR of 10.5 % during the forecast period (2021-2028).
Screening of new born in Asia Pacific region is rapidly gaining traction, owing to the highest birth rate, which is almost half of world. Therefore, countries in the Asia Pacific region are focused on various initiatives to discuss and find solutions for the increasing occurrence of neonatal diseases. For instance, in 2018, Ayushman Bharat was launched in India, which is one of the biggest people-centric schemes. As the world is gearing towards the achievement of Universal Health coverage and countries are working towards the maternal, reproductive, new born, child, and adolescent health (RMNCH+A) programme, several practices, and innovations are implemented by states, union territories, and organisations to address challenges in the maternal and child health sector in India.
Major Key Players are: Agilent Technologies, Inc, Bio-rad laboratories, Inc. Medtronic Plc, Masimo Corporation, Natus Medical Inc., Perkin Elmer, Inc., ZenTec S.A., Trivitron Healthcare Pvt Ltd, Waters Technologies Corporation, Danaher Corporation, Baebies, Inc., Parseq Lab Co. Ltd, Chromesystem Instruments and Chemicals GmbH, and RECIPE Chemicals+ Instrument GmbH.
Intent of the Newborn Screening Market Research Study:
Purchase this Premium Report (Flat USD 2000 OFF) – https://www.coherentmarketinsights.com/promo/buynow/2192
Reasons to Purchase this Report
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Newborn Screening Market Set to Take Off by 2027 To Gather Huge Revenues appeared first on Gatorledger.
Newborn Screening Market report includes historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. Newborn Screening Market offers complete, proficient report delivering market research data that is relevant for new market entrants or set up players. Key strategies of the companies operating in the market and their impact analysis have been included in the report.
Request for Sample Copy of Report at – https://www.coherentmarketinsights.com/insight/request-sample/2192
New born screening is a public health program conducted by various hospitals where new born babies are screened and identified with rare but some serious medical conditions (genetic, hormonal, or metabolic conditions) which can affect normal growth of the new born but are treatable.
New born screening includes various tests such as hearing test, urine test, dry blood test, and others, that are undertaken during initial few hours or days of an infant’s life. These tests have the potential role in preventing several health problems and death. New born screening has evolved from a simple blood and urine screening test to a more comprehensive and complex screening system for detecting over 50 different conditions. New born screening tests measures different types of markers present in infant’s blood that can either increase or decrease, if an infant has certain diseases. Recently, conditions such as congenital hypothyroidism, phenylketonuria (PKU), cystic fibrosis (CF), and about 22 other metabolic conditions can be diagnosed through new born screening tests that affect fat metabolism or protein.
The global new born screening market is estimated to be valued at US$ 1,412.2 million in 2021 and is expected to exhibit a CAGR of 10.5 % during the forecast period (2021-2028).
Screening of new born in Asia Pacific region is rapidly gaining traction, owing to the highest birth rate, which is almost half of world. Therefore, countries in the Asia Pacific region are focused on various initiatives to discuss and find solutions for the increasing occurrence of neonatal diseases. For instance, in 2018, Ayushman Bharat was launched in India, which is one of the biggest people-centric schemes. As the world is gearing towards the achievement of Universal Health coverage and countries are working towards the maternal, reproductive, new born, child, and adolescent health (RMNCH+A) programme, several practices, and innovations are implemented by states, union territories, and organisations to address challenges in the maternal and child health sector in India.
Major Key Players are: Agilent Technologies, Inc, Bio-rad laboratories, Inc. Medtronic Plc, Masimo Corporation, Natus Medical Inc., Perkin Elmer, Inc., ZenTec S.A., Trivitron Healthcare Pvt Ltd, Waters Technologies Corporation, Danaher Corporation, Baebies, Inc., Parseq Lab Co. Ltd, Chromesystem Instruments and Chemicals GmbH, and RECIPE Chemicals+ Instrument GmbH.
Intent of the Newborn Screening Market Research Study:
Purchase this Premium Report (Flat USD 2000 OFF) – https://www.coherentmarketinsights.com/promo/buynow/2192
Reasons to Purchase this Report
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Newborn Screening Market Set to Take Off by 2027 To Gather Huge Revenues appeared first on Gatorledger.
Explore more articles in the Research Reports category











